Viewing Study NCT05132218


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2025-12-26 @ 3:53 AM
Study NCT ID: NCT05132218
Status: UNKNOWN
Last Update Posted: 2021-11-24
First Post: 2021-10-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer
Sponsor: Peking University Cancer Hospital & Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module